MedPath

To know tha effect of churan and kwatha in tha management of Amavata w.s.r. to Rheumatoid Arthritis

Phase 4
Conditions
Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
Registration Number
CTRI/2022/10/046617
Lead Sponsor
Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital Paprola
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients willing for study.

Patients in the age group between 30-70 years, irrespective of sex and socio-economic status.

Patient with signs and symptoms of Amavata w.s.r. to Rheumatoid Arthritis as described in texts and fulfill the diagnostic criteria.

Exclusion Criteria

Patients not willing for the trial

Patients with age group below 30 and above 70 years.

Allergy to the trial drug.

Patients having any type of arthopathy such as neoplasm of spine,ankylosing spondylosis, osteoarthritis, traumatic arthritis and pyogenic osteomyelitis etc. Patients suffering from chronic renal, respiratory, cardiac and hepatic . disorder.

Pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in symptoms of Amavata after intervention of pathyadi churana and shunthayadi kwatha <br/ ><br> <br/ ><br>Angamarda <br/ ><br>Aruchi <br/ ><br>Trishna <br/ ><br>Alsaya <br/ ><br>Apaka <br/ ><br>Gaurava <br/ ><br>Jwara <br/ ><br>Sandhishoola <br/ ><br>Sandhishotha <br/ ><br>Sparshasahtva <br/ ><br>Vibandha <br/ ><br>Antrakujana <br/ ><br>Nidraviparyaya <br/ ><br>Praseka DahaTimepoint: 6 weeks
Secondary Outcome Measures
NameTimeMethod
Improving quality of lifeTimepoint: 6 weeks
© Copyright 2025. All Rights Reserved by MedPath